SCHEMBL10853097

SCHEMBL10853097

O=[N+]([O-])c1ccc(N(CCO)CCO)c(S(=O)(=O)O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.48
▸ NT5E P21589 2/20 0.43
▸ TSHR P16473 2/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ HTT P42858 3/20 0.42
▸ TP53 P04637 1/20 0.42
▸ PDE2A O00408 1/20 0.41
▸ PDE5A O76074 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ APEX1 P27695 1/20 0.41
▸ PDE4A P27815 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ PDE1B Q01064 1/20 0.41
▸ PMP22 Q01453 1/20 0.41
▸ PDE4B Q07343 1/20 0.41
▸ PDE4D Q08499 1/20 0.41
▸ PDE7A Q13946 1/20 0.41
▸ PDE1C Q14123 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11108653 0.83 ALDH1A1 (0.43) ALDH1A1NT5ETSHRCYP2C19HTT
SCHEMBL10502056 0.79 ALDH1A1 (0.56) ALDH1A1NT5ETSHRCYP2C19HTT
SCHEMBL7809597 0.79 ALDH1A1 (0.52) ALDH1A1TSHRHTTTP53GAA
SCHEMBL110420 0.79 ALDH1A1 (0.52) ALDH1A1TSHRHTTTP53GAA
SCHEMBL30785734 0.78 ALDH1A1 (0.56) ALDH1A1CYP2C19HTTCYP3A4POLB
SCHEMBL21410461 0.78 ALDH1A1 (0.56) ALDH1A1CYP2C19HTTCYP3A4POLB
SCHEMBL1984158 0.78 HSD17B10 (0.51) ALDH1A1TSHRHTTTP53PDE7A
SCHEMBL7472206 0.78 ALDH1A1 (0.55) ALDH1A1TSHRCYP2C19HTTTP53
SCHEMBL2088798 0.78 ALDH1A1 (0.51) ALDH1A1TSHRHTTTP53GAA
SCHEMBL11615416 0.77 ALDH1A1 (0.48) ALDH1A1NT5ETSHRCYP2C19HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11661404-B2 Prodrug compounds activated by AKR1C3 and their use for treating hyperproliferative disorders ACHILLES MEDICAL LIMITED (NZ) 2023-05-30 — — US disclosed
US-4619666-A Hair dyes containing amino-nitrobenzoic acid or amino-nitrobenzene sulfonic acids as substantive dyes HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1986-10-28 — — US disclosed
EP-0170069-A1 Hair-dyeing compositions Henkel Kommanditgesellschaft auf Aktien (DE) 1986-02-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11661404-B2 Prodrug compounds activated by AKR1C3 and their use for treating hyperproliferative disorders AKR1C2, AKR1C1, AKR1B1 ALDH1A1 61/4885NT5E 3493/4885TSHR 2919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback